Postes actifs de Nicole Keith
Sociétés | Poste | Début | Fin |
---|---|---|---|
JUNO THERAPEUTICS INC | Investor Relations Contact | 01/07/2015 | - |
SANA BIOTECHNOLOGY, INC. | Public Communications Contact | - | - |
Historique de carrière de Nicole Keith
Anciens postes connus de Nicole Keith
Sociétés | Poste | Début | Fin |
---|---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - | 01/12/2013 |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Public Communications Contact | 2 |
Investor Relations Contact | 1 |
Sectorielle
Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SANA BIOTECHNOLOGY, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Nicole Keith
- Expérience